Glutamine

Glutamine

SCHEMBL1033433

NC(=O)CC[C@H](N)C(=O)O.O=C(O)CCC(=O)C(=O)O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.70
BLM P54132 1/20 0.70
PMP22 Q01453 1/20 0.70
KMT2A Q03164 1/20 0.70
GRM8 O00222 2/20 0.61
GRM6 O15303 2/20 0.61
GRM7 Q14831 2/20 0.61
GRM4 Q14833 2/20 0.61
GSR P00390 2/20 0.61
CYP1A2 P05177 2/20 0.61
GRIN2D O15399 1/20 0.61
GRIN3B O60391 1/20 0.61
GRIK1 P39086 1/20 0.61
GRM5 P41594 1/20 0.61
GRIA1 P42261 1/20 0.61
GRIA2 P42262 1/20 0.61
GRIA3 P42263 1/20 0.61
SLC1A3 P43003 1/20 0.61
SLC1A2 P43004 1/20 0.61
SLC1A1 P43005 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamine SCHEMBL1033431 1.00 ALOX15 (0.70) ALOX15BLMPMP22KMT2AGRM8
Glutamic Acid SCHEMBL148727 0.90 GRM8 (0.75) ALOX15BLMPMP22KMT2AGRM8
D-Glutamate SCHEMBL148726 0.90 GRM8 (0.75) ALOX15BLMPMP22KMT2AGRM8
D-Glutamate SCHEMBL6138602 0.90 GRM8 (0.75) ALOX15BLMPMP22KMT2AGRM8
Alpha-Ketoglutaric Acid SCHEMBL4362701 0.89 ALOX15 (0.53) ALOX15BLMPMP22KMT2AGRM8
Glutamine SCHEMBL352341 0.86 PMP22 (0.86) ALOX15BLMPMP22KMT2AGRM8
Glutamine SCHEMBL2443861 0.86 PMP22 (0.86) ALOX15BLMPMP22KMT2AGRM8
Glutamine SCHEMBL9276090 0.86 PMP22 (0.86) ALOX15BLMPMP22KMT2AGRM8
Glutamine SCHEMBL8429219 0.86 PMP22 (0.86) ALOX15BLMPMP22KMT2AGRM8
Glutamine SCHEMBL1634485 0.86 PMP22 (0.86) ALOX15BLMPMP22KMT2AGRM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11344528-B2 Compositions for promoting the endogenous self-renewal of stem cells DISCHLER LOUIS (US) 2022-05-31 US claimed
US-11324764-B2 Methods for reducing mitochondrial dysfunction DISCHLER LOUIS (US) 2022-05-10 US claimed
US-11090320-B2 Compositions for reducing mitochondrial dysfunction DISCHLER LOUIS (US) 2021-08-17 US claimed
US-20210186922-A1 METHODS AND COMPOSITIONS FOR REDUCING EPIGENETIC AGE AND MITOCHONDRIAL DYSFUNCTION DISCHLER LOUIS (US) 2021-06-24 US claimed
US-20210161925-A1 METHODS AND COMPOSITIONS FOR REDUCING EPIGENETIC AGE AND MITOCHONDRIAL DYSFUNCTION DISCHLER LOUIS (US) 2021-06-03 US claimed
CN-101591264-A A kind of preparation method of crystal L-glutamine alpha-ketoglutarate SHANGHAI HANFEI BIOCHEMICAL TE (CN) 2009-12-02 CN claimed
US-20060198899-A1 Supplemental dietary composition for supporting muscle growth, recovery and strength IML FORMULATIONS LTD (CA) 2006-09-07 US claimed
EP-1004671-B1 PROCESS FOR PRODUCING L-GLUTAMIC ACID BY FERMENTATION METHOD AJINOMOTO KK (JP) 2006-01-11 EP claimed
EP-1004671-A1 PROCESS FOR PRODUCING L-GLUTAMIC ACID BY FERMENTATION METHOD Ajinomoto Co., Inc. (JP) 2000-05-31 EP claimed
US-12610956-B2 Agricultural compositions comprising remodeled nitrogen fixing microbes PIVOT BIO, INC. (US) 2026-04-28 US disclosed
US-12612639-B2 Guided microbial remodeling, a platform for the rational improvement of microbial species for agriculture PIVOT BIO, INC. (US) 2026-04-28 US disclosed
US-20260107948-A1 AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBES PIVOT BIO INC (US) 2026-04-23 US disclosed
US-12575568-B2 Composition for promoting the growth of legumes CH BIOTECH R&D CO., LTD. (TW) 2026-03-17 US disclosed
US-20260041099-A1 AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBES PIVOT BIO INC (US) 2026-02-12 US disclosed
US-6107547-A PRODUCING PLANTS WITH IMPROVED AGRONOMIC/NUTRITIONAL TRAITS SUCH AS FASTER RATE OF GROWTH AND GREATER PROTEIN CONTENT BY IDENTIFYING PLANT ECTOPICALLY OVEREXPRESSING CYTOSOLIC GLUTAMINE SYNTHETASE, SCREENING FOR TRAITS, AND SELECTING NEW YORK UNIVERSITY (US) 2000-08-22 US disclosed
EP-1004671-A1 PROCESS FOR PRODUCING L-GLUTAMIC ACID BY FERMENTATION METHOD Ajinomoto Co., Inc. (JP) 2000-05-31 EP disclosed
US-5955651-A Transgenic plants that exhibit enhanced nitrogen assimilation NEW YORK UNIVERSITY (US) 1999-09-21 US disclosed
EP-0722494-A4 TRANSGENIC PLANTS THAT EXHIBIT ENHANCED NITROGEN ASSIMILATION UNIV NEW YORK (US) 1999-06-23 EP disclosed
EP-0722494-A1 TRANSGENIC PLANTS THAT EXHIBIT ENHANCED NITROGEN ASSIMILATION NEW YORK UNIVERSITY (US) 1996-07-24 EP disclosed
WO-1995009911-A1 TRANSGENIC PLANTS THAT EXHIBIT ENHANCED NITROGEN ASSIMILATION NEW YORK UNIVERSITY (US) 1995-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612639-B2 Guided microbial remodeling, a platform for the rational improvement of microbial species for agriculture GLUL, ARG1, PGLS ALOX15 4670/4885BLM 3509/4885PMP22 3772/4885
US-20260041099-A1 AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBES AMPD2, DDC, INMT ALOX15 4454/4885BLM 2185/4885PMP22 2603/4885
US-12610956-B2 Agricultural compositions comprising remodeled nitrogen fixing microbes GLUL, IPMK, GNMT ALOX15 4588/4885BLM 1241/4885PMP22 3941/4885
US-20260107948-A1 AGRICULTURAL COMPOSITIONS COMPRISING REMODELED NITROGEN FIXING MICROBES GLUL, IPMK, GNMT ALOX15 4588/4885BLM 1241/4885PMP22 3941/4885
US-12575568-B2 Composition for promoting the growth of legumes SLC6A13, SLC6A1, NAT1 ALOX15 2309/4885BLM 3539/4885PMP22 2814/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.